Remap Consulting GmbH
Remap Consulting provides an integrated approach to pharmaceutical pricing & market access solutions.
We are a specialist pricing, reimbursement and market access consultancy offering an integrated, evidence-based approach to optimising market access. Our strength lies in our ability to understand the market access challenges from your perspective and to develop payer-focused solutions tailored to your business needs.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
MDNT
MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.
Onyx Health
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Company Details
Latest Content from PMHub
Data-driven policy and market access firm Avalere joins Fishawack Health
Press Releases | June 16, 2022 | Avalere Health
Fishawack Health bolsters its commercialization service offering with its largest addition to date, welcoming US-based policy, market access, and transformation leader Avalere.
Cuttsy+Cuttsy gain highly regarded PIF Partner status
Press Releases | June 16, 2022 | Cuttsy + Cuttsy
As official PIF Partners, Cuttsy+Cuttsy will be supporting the Patient Information Forum raise awareness of the PIF TICK.
Science for science sake
White Papers and Resources | June 16, 2022 | Dice Medical Communications
Like great works of art, there was no ‘reason’ for certain scientific endeavours, but this ‘just for the sake of it’ philosophy is now delivering tangible benefits. (article written 3rd...
Embrace mental health first aiders for better work wellbeing
White Papers and Resources | June 15, 2022 | Page & Page Health
Mental health first aid can work as a vital steppingstone to instilling good mental health practices into wider company culture and ensure everyone knows what to be looking out for...
Celebrating World Blood Donor Day
White Papers and Resources | June 15, 2022 | Innovative Trials
Each 14th June World Blood Donor day is celebrated around the world to spread awareness around the importance of giving blood.
Spending on anti-depressants soars as the pandemic’s effect on NHS prescribing patterns is revealed
Press Releases | June 13, 2022 | Wilmington Healthcare
Wilmington Healthcare’s State of the Nation prescribing report shows that spending on sertraline, commonly used to treat depression and anxiety, increased by 305.5% between 2019/20 and 2020/21 while overall spend...
Accelerating patient recruitment in clinical trials post COVID-19
Videos and Podcasts | June 13, 2022 | Innovative Trials
Patient recruitment is arguably one of the most important aspects of a clinical trial. Without enough participants, trials will inevitably fail, meaning potentially effective therapies will not be brought to...
Diversity in Clinical Trials: A more inclusive approach in patient recruitment
Videos and Podcasts | June 13, 2022 | Innovative Trials
We have seen a growing focus on patient diversity in clinical trials in recent years, but the COVID-19 vaccine trials in particular have highlighted the importance of achieving diverse patient...
Part 4 of 4, of the Medscape video interview series
Videos and Podcasts | June 10, 2022 | Medscape Education
Dr. Hansa Bhargava MD interviews Dr. Maria Victoria Mateos on the most important abstracts to look out for in multiple myeloma and the potential implications of these data for managing patients...
How whole genome sequencing is revolutionising the rare disease patient experience
White Papers and Resources | June 10, 2022 | IGNIFI
In this white paper, we discuss how whole genome sequencing (WGS) projects and the data sets they produce are paving the way for developments in research, diagnosis, and early interventions...